“…Subretinal blood can act as a barrier to block metabolic exchange, causing degenerative changes of the RPE and outer retina. 36 In this study, none of the following were shown to be related to visual outcomes: age, gender, subretinal haemorrhage size, duration from subretinal haemorrhage to VH, duration from VH to PPV, preoperative treatment with intravitreal bevacizumab injection, or PDT. Cases with systemic disease (DM or HTN) showed a borderline relationship (Fisher's exact test, P ¼ 0.05) with poorer visual outcomes.…”